always Carbon Dioxide-Oxygen-Nitrogen Mixture Dosage Form: gas Print this page Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here. Carbon Dioxide-Oxygen-Nitrogen Mixture COMPRESSED GAS, OXIDIZING, N.O.S. UN3156 ( _____% ________________, _____% ________________, _____% ________________) DO NOT REMOVE THIS PRODUCT LABEL. NON-FLAMMABLE GAS 2 OXIDIZER ROBERTS OXYGEN COMPANY, INC. ROCKVILLE, MD 20855 PHONE: 301-948-8100 Rx ONLY. WARNING: ADMINISTRATION OF THIS GAS MIXTURE MAY BE HAZARDOUS OR CONTRAINDICATED. FOR USE ONLY BY OR UNDER THE SUPERVISION OF A LICENSED PRACTITIONER WHO IS EXPERIENCED IN THE USE AND ADMINISTRATION OF GAS MIXTURES, AND IS FAMILIAR WITH THE INDICATIONS, EFFECTS, DOSAGES, METHODS, AND FREQUENCY AND DURATION OF ADMINISTRATION, AND WITH THE HAZARDS, CONTRAINDICATIONS AND SIDE EFFECTS AND THE PRECAUTIONS TO BE TAKEN. WARNING: HIGH PRESSURE GAS. VIGOROUSLY ACCELERATES COMBUSTION. KEEP OIL AND GREASE AWAY. USE ONLY WITH EQUIPMENT CLEANED FOR OXYGEN SERVICE AND RATED FOR CYLINDER PRESSURE. OPEN VALVE SLOWLY. CLOSE VALVE AFTER EACH USE AND WHEN EMPTY. USE IN ACCORDANCE WITH MSDS AND CGA PAMPHLET P-1 AND P-2. Carbon Dioxide-Oxygen-Nitrogen Mixture Carbon Dioxide-Oxygen-Nitrogen Mixture gas Product Information Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC:46123-041 Route of Administration RESPIRATORY (INHALATION) DEA Schedule Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Oxygen (Oxygen) Oxygen 250 mL in 1 L Carbon Dioxide (Carbon Dioxide) Carbon Dioxide 100 mL in 1 L Inactive Ingredients Ingredient Name Strength Nitrogen Packaging # Item Code Package Description 1 NDC:46123-041-01 651 L in 1 CYLINDER 2 NDC:46123-041-02 6116 L in 1 CYLINDER Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved medical gas 01/01/1966 Labeler - Roberts Oxygen Company, Inc. (042646877) Revised: 12/2009 Roberts Oxygen Company, Inc. FEATURED: CAR-T Cell Therapy Overview Mechanism of Action KTE-C19 Studies KTE-C19 Cancer Targets Adverse Events Manufacturing Recently Approved Lonhala Magnair Lonhala Magnair (glycopyrrolate) is a long-acting muscarinic antagonist (LAMA) bronchodilator for... Ozempic Ozempic (semaglutide) is a glucagon-like peptide-1 (GLP-1) analog administered once-weekly for the... Ogivri Ogivri (trastuzumab-dkst) is a HER2 / neu receptor antagonist biosimilar to Herceptin indicated for... Sublocade Sublocade (buprenorphine) is a once-monthly injectable partial opioid agonist formulation for the... More i thought
which might be Carbon Dioxide-Oxygen-Nitrogen Mixture unhurt
EmoticonEmoticon